IRVING, Texas -- Orlando Scandrick has an obviously biased opinion, but the Dallas Cowboys cornerback firmly believes the NFL’s new drug policy is a significant improvement.

The fact that offseason amphetamine use will no longer be classified under the performance-enhancing category has been the subject of much discussion because the suspensions of players such as Scandrick and Denver Broncos receiver Wes Welker were retroactively overturned, allowing them to return to their teams two weeks earlier than originally scheduled.

However, the implementation of testing for human growth hormone is the headline of the new policy, a change that will have a far greater long-term impact.

“I think it was right,” Scandrick said. “We are talking about cleaning up our game and keeping a clean game. We are not cleaning up our game if we are suspending guys for stimulants and not testing guys for human growth hormones, so I think it kind of went hand in hand.

“I think this is better for the game and I think now that we have HGH test implemented, we make sure our game stays clean.”

Scandrick tested positive for amphetamine after taking the recreational drug MDMA, known as “Molly,” during an April vacation to Mexico. He readily admits to an inexcusable lack of judgment and will be frequently tested under the NFL’s substance-abuse program as a first-time offender.

But Scandrick was adamant from the time his suspension became public that he did not take a substance to enhance his performance on the field. This change in the drug policy ensures that the record will reflect that.

“Not having that on my record, not having a failed test for a performance-enhancing drug, I mean that’s big,” Scandrick said. “All of that not being on my record and everyone knowing I’m not a cheater. Because I’m not and I was adamant from the time I got caught for this. I am not a cheater.”